Dr. Shenot Patrick J. Shenot, M.D., F.A.C.S.

Contact Dr. Shenot

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Medical School
SUNY at Stony Brook, 1991

Residency
General Surgery, Thomas Jefferson University Hospital, 1993
Urology, Thomas Jefferson University Hospital, 1997

Fellowship
Neurourology, Thomas Jefferson University Hospital, 1999

Board Certification
American Board of Urology, 2000, 2010 (recertification)

University Appointment
Vice Chairman, Academic Affairs
Residency Program Director
Associate Professor

Hospital Appointment
Director, Urodynamics Laboratory

Research and Clinical Interests
Dr. Shenot serves as Residency Program Director and Vice Chairman for Academic Affairs of the Department of Urology at Jefferson Medical College of Thomas Jefferson University. His major clinical interests are in neurourology, voiding dysfunction, and urologic care of spinal cord injured patients.

Dr. Shenot is a member of the American Urological Association, American College of Surgeons, American Spinal Cord Injury Association, American Paraplegia Society, International Continence Society and the Society for  Female Urology and Urodynamics.

Dr. Shenot is a principal investigator  on many ongoing clinical trials involving genitourinary disorders. He has written numerous book chapters and  peer-reviewed publications. His research focuses on the treatment of lower urinary tract dysfunction particularly bladder augmentation and both electrical and pharmacologic neuromodulation ,

He has been recognized in Castle Connolly's  “ America’s Top Doctors” Best Doctors in America®   the Consumers' Research Council of America  “Guide to America’s Top Surgeons” as well as  Philadelphia Magazine's "Top Doctors" list . He has made over 70 presentations at national and international conferences and has been the recipient of awards for excellence in research from the American Spinal Injury Association.


Publications

Most recent Peer-reviewed Publications

  1. Office-based Care of the Neurogenic Bladder Patient
  2. Uropharmacology in primary care: 2010 update.
  3. Update on neuromodulation for frequency, urgency, retention, and neurogenic voiding dysfunction
  4. Bladder augmentation using an autologous neo-bladder construct
  5. RE: Secondary malignancies in different forms of urinary diversion using isolated gut [8] (multiple letters)
  6. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: A multicenter, blinded, randomized, placebo-controlled trial
  7. Urodynamics and voiding dysfunction
  8. Transurethral microwave thermotherapy of the prostate without intravenous sedation: Results of a single United States center using both low- and high-energy protocols
  9. Removal of UroLume endoprosthesis: Experience of the North American study group for detrusor-sphincter dyssynergia application
  10. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia
  11. Extraperitoneal laparoscopic nephrolysis for the treatment of chyluria
  12. Early predictors of bladder recovery and urodynamics after spinal cord injury
  13. A molecular marker for the development of interstitial cystitis in a rat model: Isoactin gene expression
  14. In-vivo whole bladder response to anticholinergic and musculotropic agents in spinal cord injured rats
  15. Fascial sling correction of kinked efferent limb in patients with continent diversion and catheterization difficulty
  16. Mixed urinary incontinence secondary to lead poisoning
  17. Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen.
  18. Urological symptomatology in patients with reflex sympathetic dystrophy
  19. Radial dilatation in the insertion of the multi-component inflatable penile prosthesis
  20. Latex allergy manifested in urological surgery and care of adult spinal cord injured patients

View All Publications